1. Home
  2. CCO vs NVCR Comparison

CCO vs NVCR Comparison

Compare CCO & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clear Channel Outdoor Holdings Inc.

CCO

Clear Channel Outdoor Holdings Inc.

HOLD

Current Price

$2.39

Market Cap

1.2B

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$17.64

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCO
NVCR
Founded
1995
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Advertising
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2005
2015

Fundamental Metrics

Financial Performance
Metric
CCO
NVCR
Price
$2.39
$17.64
Analyst Decision
Hold
Buy
Analyst Count
5
6
Target Price
$2.12
$28.08
AVG Volume (30 Days)
4.3M
1.7M
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
110.81
21.79
EPS
N/A
N/A
Revenue
$1,604,140,000.00
$655,353,000.00
Revenue This Year
$5.35
$7.72
Revenue Next Year
$4.26
$6.74
P/E Ratio
N/A
N/A
Revenue Growth
6.57
8.28
52 Week Low
$1.00
$9.82
52 Week High
$2.43
$20.05

Technical Indicators

Market Signals
Indicator
CCO
NVCR
Relative Strength Index (RSI) 50.91 67.38
Support Level $2.37 $12.66
Resistance Level $2.41 N/A
Average True Range (ATR) 0.01 1.01
MACD -0.00 0.23
Stochastic Oscillator 25.00 82.42

Price Performance

Historical Comparison
CCO
NVCR

About CCO Clear Channel Outdoor Holdings Inc.

Clear Channel Outdoor Holdings Inc is a provider of out-of-home advertising solutions. The company offers advertisers an opportunity to reach mass audiences across various high-traffic public spaces, by using its diverse portfolio of assets including roadside billboards, street furniture, and airport displays. Its reportable segments are; America (U.S. operations excluding airports), Airports (U.S. and Caribbean airport operations), and Other. A majority of its revenue is generated from the America segment which generates revenue from the sale of advertising on printed and digital out-of-home advertising displays such as bulletins, posters, street furniture, and others. Geographically, the company generates maximum revenue from the United States followed by Singapore.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: